Long-term complications of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Long-term complications of COVID-19

Authors: Amar D. Desai,*Michael Lavelle,*Brian C. Boursiquot, and Elaine Y. Wan Am J Physiol Cell Physiol. 2022 Jan 1; 322(1): C1–C11.Published online 2021 Nov 24. doi:  10.1152/ajpcell.00375.2021PMCID: PMC8721906PMID: 34817268 Abstract SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of people worldwide. As our experience with this virus continues to grow, our understanding of both short-term and […]

Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Posted on | Posted on John Murphy | Leave a Comment on Prevalence of organ impairment in Long COVID patients 6 and 12 months after initial symptoms

Authors:  Pooja Toshniwal PahariaMar 24 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* preprint server, researchers assessed the prevalence of organ impairment in long coronavirus disease 2019 (COVID-19) six months and a year post-COVID-19 at London and Oxford. Multi-organ impairment associated with long COVID-19 is a significant health burden. Standardized multi-organ evaluation […]

Never Had Covid? You May Hold KeyTo Beating the Virus

Posted on | Posted on John Murphy | Leave a Comment on Never Had Covid? You May Hold KeyTo Beating the Virus

Authors: Madison Muller 02:30 PM IST, 30 Mar 2022 06:48 PM IST, 30 Mar 2022 Read more at:  https://www.bloombergquint.com/onweb/never-had-covid-you-may-hold-key-to-beating-the-virusCopyright © Bloomberg More than half of Americans may have never had Covid, according to U.S. government data, leaving scientists wondering whether those who’ve avoided the novel coronavirus might actually be immune to the virus altogether. This […]

Digit ratios and their asymmetries as risk factors of developmental instability and hospitalization for COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Digit ratios and their asymmetries as risk factors of developmental instability and hospitalization for COVID-19

Authors: A. Kasielska-Trojan, J. T. Manning, M. Jabłkowski, J. Białkowska-Warzecha, A. L. Hirschberg & B. Antoszewski  Scientific Reports volume 12, Article number: 4573 (2022) Cite this article Article Open Access Published: 17 March 2022 Abstract COVID-19 presents with mild symptoms in the majority of patients but in a minority it progresses to acute illness and hospitalization. Here we consider whether markers for prenatal sex hormones and postnatal stressors […]

The length of your fingers may determine how sick you get from COVID-19

Posted on | Posted on John Murphy | Leave a Comment on The length of your fingers may determine how sick you get from COVID-19

Authors: Chris Melore Studyfinds.org March 28, 2022 Your risk of ending up in the hospital with COVID-19 may literally be in your own hands. A new study finds finger length displays a link to a person’s sex hormone levels. What does this have to do with COVID-19? Researchers at Swansea University say a patient’s testosterone […]

Different SARS-CoV-2 variants may give rise to different long COVID symptoms, study suggests

Posted on | Posted on John Murphy | Leave a Comment on Different SARS-CoV-2 variants may give rise to different long COVID symptoms, study suggests

Italian study of long-COVID patients suggests those infected with the Alpha variant experienced different neurological and emotional symptoms compared to those who contracted the original form of SARS-CoV-2 Authors: EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES 24-MAR-2022 New research to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) […]

What You Should Know About Treating Covid-19

Posted on | Posted on John Murphy | Leave a Comment on What You Should Know About Treating Covid-19

Some therapies have been shown to work in clinical studies and other research Authors: Jared S. Hopkins Mar. 21, 2022 4:47 pm ET The Wall Street Journal The Food and Drug Administration authorized the first antiviral pills to treat Covid-19 from Pfizer Inc. and Merck & Co. and partner Ridgeback Biotherapeutics LP in December. The authorizations came after each drugmaker’s pill […]

Spike protein in mRNA COVID vaccines: One of the most bioactive substances known to mankind

Posted on | Posted on John Murphy | Leave a Comment on Spike protein in mRNA COVID vaccines: One of the most bioactive substances known to mankind

Source: https://www.planet-today.com/2022/03/spike-protein-in-mrna-covid-vaccines.html The spike protein present in Wuhan coronavirus (COVID-19) vaccines is one of the most bioactive and potentially damaging substances known to mankind. It penetrates the blood-brain barrier, cell nucleus and even affects DNA replication. The spike protein appears to reprogram the immune system in a strange way. The BNT162b2 mRNA vaccine against the COVID-19 […]

Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Posted on | Posted on John Murphy | Leave a Comment on Uptake of SARS-CoV-2 spike protein in human cerebrovascular cells

Authors:  Bhavana Kunkalikar Mar 24 2022 Reviewed by Danielle Ellis, B.Sc. BioRxiv A recent study posted to the bioRxiv* preprint server assessed the uptake of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein in human cerebrovascular cells via the lipid raft ganglioside.   Various studies have reported the effects of coronavirus disease 2019 (COVID-19) on […]